Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 540.55
+6.15 (1.15%)
Jun 19, 2026, 3:29 PM IST
Thyrocare Technologies Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Thyrocare Technologies stock has a consensus rating of "Strong Buy" and an average price target of ₹600.00. The average 1-year stock price forecast is 11.00% higher than the current stock price, while the lowest is ₹550.00 (+1.75%) and the highest is ₹650.00 (+20.25%).
Price Target: ₹600.00 (+11.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Thyrocare Technologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Oct '25 | Jan '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
9.80B
from 8.29B
Increased by 18.15%
Revenue Next Year
11.46B
from 9.80B
Increased by 16.95%
EPS This Year
11.32
from 10.54
Increased by 7.40%
EPS Next Year
13.96
from 11.32
Increased by 23.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 10.0B | ||
| Avg | 9.8B | ||
| Low | 9.7B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.3% | ||
| Avg | 18.1% | ||
| Low | 17.1% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 12.50 | ||
| Avg | 11.32 | ||
| Low | 8.00 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 18.6% | ||
| Avg | 7.4% | ||
| Low | -24.1% |